vs
GE医疗（CCRN）与UiPath, Inc.（PATH）财务数据对比。点击上方公司名可切换其他公司
UiPath, Inc.的季度营收约是GE医疗的1.7倍（$411.1M vs $236.8M），UiPath, Inc.净利率更高（48.4% vs -35.0%，领先83.4%），UiPath, Inc.同比增速更快（15.9% vs -23.6%），UiPath, Inc.自由现金流更多（$25.1M vs $16.1M），过去两年UiPath, Inc.的营收复合增速更高（0.7% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
CCRN vs PATH — 直观对比
营收规模更大
PATH
是对方的1.7倍
$236.8M
营收增速更快
PATH
高出39.5%
-23.6%
净利率更高
PATH
高出83.4%
-35.0%
自由现金流更多
PATH
多$9.0M
$16.1M
两年增速更快
PATH
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $411.1M |
| 净利润 | $-82.9M | $198.8M |
| 毛利率 | — | 83.3% |
| 营业利润率 | -30.2% | 3.2% |
| 净利率 | -35.0% | 48.4% |
| 营收同比 | -23.6% | 15.9% |
| 净利润同比 | -2109.7% | 1966.2% |
| 每股收益（稀释后） | $-2.56 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNPATH
| Q4 25 | $236.8M | $411.1M | ||
| Q3 25 | $250.1M | $361.7M | ||
| Q2 25 | $274.1M | $356.6M | ||
| Q1 25 | $293.4M | $423.6M | ||
| Q4 24 | $309.9M | $354.7M | ||
| Q3 24 | $315.1M | $316.3M | ||
| Q2 24 | $339.8M | $335.1M | ||
| Q1 24 | $379.2M | $405.3M |
净利润CCRNPATH
| Q4 25 | $-82.9M | $198.8M | ||
| Q3 25 | $-4.8M | $1.6M | ||
| Q2 25 | $-6.7M | $-22.6M | ||
| Q1 25 | $-490.0K | $51.8M | ||
| Q4 24 | $-3.8M | $-10.7M | ||
| Q3 24 | $2.6M | $-86.1M | ||
| Q2 24 | $-16.1M | $-28.7M | ||
| Q1 24 | $2.7M | $33.9M |
毛利率CCRNPATH
| Q4 25 | — | 83.3% | ||
| Q3 25 | 20.4% | 82.2% | ||
| Q2 25 | 20.4% | 82.1% | ||
| Q1 25 | 20.0% | 84.8% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | 20.4% | 80.0% | ||
| Q2 24 | 20.8% | 83.5% | ||
| Q1 24 | 20.4% | 86.8% |
营业利润率CCRNPATH
| Q4 25 | -30.2% | 3.2% | ||
| Q3 25 | -2.4% | -5.6% | ||
| Q2 25 | -2.1% | -4.6% | ||
| Q1 25 | -0.3% | 7.9% | ||
| Q4 24 | -1.1% | -12.2% | ||
| Q3 24 | 0.9% | -32.7% | ||
| Q2 24 | -5.7% | -14.8% | ||
| Q1 24 | 0.8% | 3.7% |
净利率CCRNPATH
| Q4 25 | -35.0% | 48.4% | ||
| Q3 25 | -1.9% | 0.4% | ||
| Q2 25 | -2.4% | -6.3% | ||
| Q1 25 | -0.2% | 12.2% | ||
| Q4 24 | -1.2% | -3.0% | ||
| Q3 24 | 0.8% | -27.2% | ||
| Q2 24 | -4.7% | -8.6% | ||
| Q1 24 | 0.7% | 8.4% |
每股收益（稀释后）CCRNPATH
| Q4 25 | $-2.56 | $0.37 | ||
| Q3 25 | $-0.15 | $0.00 | ||
| Q2 25 | $-0.20 | $-0.04 | ||
| Q1 25 | $-0.02 | $0.09 | ||
| Q4 24 | $-0.13 | $-0.02 | ||
| Q3 24 | $0.08 | $-0.15 | ||
| Q2 24 | $-0.47 | $-0.05 | ||
| Q1 24 | $0.08 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $1.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $1.9B |
| 总资产 | $449.0M | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCRNPATH
| Q4 25 | $108.7M | $1.4B | ||
| Q3 25 | $99.1M | $1.4B | ||
| Q2 25 | $81.2M | $1.6B | ||
| Q1 25 | $80.7M | $1.6B | ||
| Q4 24 | $81.6M | $1.6B | ||
| Q3 24 | $64.0M | $1.7B | ||
| Q2 24 | $69.6M | $1.9B | ||
| Q1 24 | $5.2M | $1.9B |
股东权益CCRNPATH
| Q4 25 | $322.8M | $1.9B | ||
| Q3 25 | $408.1M | $1.7B | ||
| Q2 25 | $412.2M | $1.7B | ||
| Q1 25 | $418.2M | $1.8B | ||
| Q4 24 | $419.0M | $1.7B | ||
| Q3 24 | $424.7M | $1.8B | ||
| Q2 24 | $433.3M | $2.0B | ||
| Q1 24 | $462.4M | $2.0B |
总资产CCRNPATH
| Q4 25 | $449.0M | $2.9B | ||
| Q3 25 | $538.2M | $2.6B | ||
| Q2 25 | $553.8M | $2.6B | ||
| Q1 25 | $576.2M | $2.9B | ||
| Q4 24 | $589.3M | $2.7B | ||
| Q3 24 | $597.4M | $2.7B | ||
| Q2 24 | $602.9M | $2.8B | ||
| Q1 24 | $648.4M | $3.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $25.1M |
| 自由现金流率自由现金流/营收 | 6.8% | 6.1% |
| 资本支出强度资本支出/营收 | 0.9% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.14× |
| 过去12个月自由现金流最近4个季度 | $40.1M | — |
8季度趋势，按日历期对齐
经营现金流CCRNPATH
| Q4 25 | $18.2M | $28.3M | ||
| Q3 25 | $20.1M | $41.6M | ||
| Q2 25 | $4.2M | $119.0M | ||
| Q1 25 | $5.7M | $146.1M | ||
| Q4 24 | $24.2M | $28.1M | ||
| Q3 24 | $7.5M | $46.4M | ||
| Q2 24 | $82.4M | $100.0M | ||
| Q1 24 | $6.0M | $145.6M |
自由现金流CCRNPATH
| Q4 25 | $16.1M | $25.1M | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.3M | $106.2M | ||
| Q1 25 | $3.8M | $138.7M | ||
| Q4 24 | $21.7M | $23.2M | ||
| Q3 24 | $6.3M | $45.0M | ||
| Q2 24 | $79.6M | $98.8M | ||
| Q1 24 | $3.8M | $141.8M |
自由现金流率CCRNPATH
| Q4 25 | 6.8% | 6.1% | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 0.8% | 29.8% | ||
| Q1 25 | 1.3% | 32.7% | ||
| Q4 24 | 7.0% | 6.5% | ||
| Q3 24 | 2.0% | 14.2% | ||
| Q2 24 | 23.4% | 29.5% | ||
| Q1 24 | 1.0% | 35.0% |
资本支出强度CCRNPATH
| Q4 25 | 0.9% | 0.8% | ||
| Q3 25 | 0.9% | 0.0% | ||
| Q2 25 | 0.7% | 3.6% | ||
| Q1 25 | 0.6% | 1.7% | ||
| Q4 24 | 0.8% | 1.4% | ||
| Q3 24 | 0.4% | 0.4% | ||
| Q2 24 | 0.8% | 0.4% | ||
| Q1 24 | 0.6% | 0.9% |
现金转化率CCRNPATH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 26.25× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
